Pretreatment 18F‐FDG uptake heterogeneity may predict treatment outcome of combined Trastuzumab and Pertuzumab therapy in patients with metastatic HER2 positive breast cancer.

Details

Language :

English

ISSN :

17405025

Volume :

23

Issue :

1

Database :

Supplemental Index

Journal :

Cancer Imaging

Publication Type :

Academic Journal

Accession number :

172019661

Full Text :

https://doi.org/10.1186/s40644-023-00608-0